Ali Behbahani bought $15.0M of SpyGlass Pharma (SGP)

Executed Feb 9, disclosed Feb 11, 2 days later.

Value, as filed

$15.0M

937,500 sh × $16.00

Executed

Feb 9

the trade date, as filed

Disclosed

Feb 11

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

-5.7%

+6.2% from execution

Over the 21 trading sessions from the disclosed entry session (Feb 11), the stock returned -5.7% (delay-adjusted); from the execution session (Feb 9), +6.2%. Derived: entry at the session's open, exit at the close 20 sessions later.

The filer

AB Ali Behbahani Director profile →

Ali Behbahani (Director) filed 1 Form 4 report in the trailing twelve months (1 purchase, 0 sales), most often in ADAP. Across 1 priced purchase filing, the average 21-session return was +6.2% from execution and -5.7% from disclosure (delay-adjusted; derived). The largest single filing was $15.0M of SGP (937,500 sh × $16.00, as filed), executed Feb 9.

The name

SGP SGP SGP · 15 filings in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→